'Young blood' company Ambrosia halts patient treatments after FDA warning

A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss, NBC News reports.